First Dengue Vaccine Phase 3 Clinical Trial Kicks off at KIMS
Bhubaneswar, Sept 2: The third phase of the clinical trial for India’s first indigenous dengue vaccine, ‘DengiAll,’ commenced today at the Kalinga Institute of Medical Sciences (KIMS) here. This trial aims to evaluate the efficacy of the indigenous tetravalent dengue vaccine developed by Panacea Biotec, in collaboration with the Indian Council of Medical Research (ICMR). KIMS…
